https://orcid.org/0000-0002-8924-935X
References
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239‐245. doi:10.1038/clpt.1981.154
- Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47(1):45–68. doi:10.1183/13993003.00583-201526699723
- Dolton MJ, McLachlan AJ. Voriconazole pharmacokinetics and exposure–response relationships: assessing the links between exposure, efficacy and toxicity. Int J Antimicrob Agents. 2014;44(3):183–193. doi:10.1016/j.ijantimicag.2014.05.01925106074
- Levine MT, Chandrasekar PH. Adverse effects of voriconazole: over a decade of use. Clin Transplant. 2016;30(11):1377–1386. doi:10.1111/ctr.1283427581783
- Purkins L, Wood N, Greenhalgh K, et al. Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety. Br J Clin Pharmacol. 2016;56(s1):2–9. doi:10.1046/j.1365-2125.2003.01993.x
- Benitez LL, Carver PL. Adverse effects associated with long-term administration of azole antifungal agents. Drugs. 2019;1–21. doi:10.1007/s40265-019-01127-8
- Hong L, Lin W. A case report of elevated serum cholesterol and triglyceride induced by itraconazole. Chin J Clin Pharm Ther. 2010;08:886–887.
- Björkhem I, Lütjohann D, Breuer O, Sakinis A, Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J Biol Chem. 1997;272(48):30178–30184. doi:10.1074/jbc.272.48.301789374499
- Lund EG, Xie C, Kotti T, Turley SD, Dietschy JM, Russell DW. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem. 2003;278:22980–22988. doi:10.1074/jbc.M30341520012686551
- Liu H, Pathak P, Boehme S, et al. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. J Lipid Res. 2016;57(10):1831–1844. doi:10.1194/jlr.M06980727534992
- Li T, Chiang JYL. Bile acids as metabolic regulators. Curr Opin Gastroenterol. 2015;31(2):159–165. doi:10.1097/MOG.000000000000015625584736
- Zanetti HR, Roever L, Goncalves A, et al. Human immunodeficiency virus infection, antiretroviral therapy, and statin: a clinical update. Curr Atheroscler Rep. 2018;20(2):9. doi:10.1007/s11883-018-0708-z29423787